Return on investment - most recent fiscal year 16.16 ...

Singapore government, Societe Generale, Abu Dhabi Investment Authority, BNP Paribas, BofA Securities,... Dec 02, 2024 20:02 Cipla Recalls Generic Drug in US: Broken Tablets - FDA Cipla is recalling ...

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Cipla share will remain in focus on Thursday after the company received the nod from Central Drugs Standard Control Organisation (CDSCO) for the exclusive distribution and marketing of Afrezza - ...

Cipla received approval from CDSCO to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers a non-injectable alternative for adults with type 1 and type ...

An “inhaled insulin” is set to join the repertoire of options available to people with diabetes, as drugmaker Cipla completes last mile procedures to import Afrezza from US’ MannKind ...

Apart from the above, the company also develops medicines to treat a few other conditions. With a market capitalization exceeding Rs.517 billion (7.9 billion USD), Cipla is reported to be one of the ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Xiaomi is a privately owned company that designs, develops, and sells smartphones, an Android-based OS, and other consumer electronics. Xiaomi also makes fitness trackers, TVs, air purifiers, and ...

Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.